Literature DB >> 29705821

Higher than standard meropenem and linezolid dosages needed for appropriate treatment of an intracerebral hemorrhage patient with augmented renal clearance.

Pier Giorgio Cojutti1,2, Cristina Barbarino3, Amato De Monte3, William Hope4, Federico Pea5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29705821     DOI： 10.1007/s00228-018-2465-x

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  10 in total

1.  Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R.

Authors:  Michael N Neely; Michael G van Guilder; Walter M Yamada; Alan Schumitzky; Roger W Jelliffe
Journal:  Ther Drug Monit       Date:  2012-08       Impact factor: 3.681

2.  Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational study.

Authors:  Cédric Carrié; Laurent Petit; Nicolas d'Houdain; Noemie Sauvage; Vincent Cottenceau; Melanie Lafitte; Cecile Foumenteze; Quentin Hisz; Deborah Menu; Rachel Legeron; Dominique Breilh; Francois Sztark
Journal:  Int J Antimicrob Agents       Date:  2017-11-24       Impact factor: 5.283

3.  Pharmacokinetics of linezolid in plasma and cerebrospinal fluid in patients with cerebral hemorrhage post-surgical intervention.

Authors:  Yan Tang; Lingti Kong; Chenchen Wu; Xiaohua Zhang; Guoyu Lu; Xiaofei Wu
Journal:  Eur J Clin Pharmacol       Date:  2017-03-24       Impact factor: 2.953

4.  Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: a pharmacokinetics/pharmacodynamics-based approach.

Authors:  Federico Pea; Pierluigi Viale; Piergiorgio Cojutti; Mario Furlanut
Journal:  Antimicrob Agents Chemother       Date:  2012-10-08       Impact factor: 5.191

5.  Association between augmented renal clearance and clinical failure of antibiotic treatment in brain-injured patients with ventilator-acquired pneumonia: A preliminary study.

Authors:  Cédric Carrie; Merry Bentejac; Vincent Cottenceau; Françoise Masson; Laurent Petit; Jean-François Cochard; François Sztark
Journal:  Anaesth Crit Care Pain Med       Date:  2017-07-26       Impact factor: 4.132

6.  Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients.

Authors:  Federico Pea; Pierluigi Viale; Piergiorgio Cojutti; Barbara Del Pin; Eleonora Zamparini; Mario Furlanut
Journal:  J Antimicrob Chemother       Date:  2012-05-02       Impact factor: 5.790

7.  Augmented Renal Clearance in Patients with Subarachnoid Hemorrhage.

Authors:  Casey C May; Shaily Arora; Sara E Parli; Justin F Fraser; Melissa Thompson Bastin; Aaron M Cook
Journal:  Neurocrit Care       Date:  2015-12       Impact factor: 3.210

Review 8.  Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections.

Authors:  Alasdair P MacGowan
Journal:  J Antimicrob Chemother       Date:  2003-05       Impact factor: 5.790

9.  Population pharmacokinetics of meropenem during continuous infusion in surgical ICU patients.

Authors:  Martin G Kees; Iris K Minichmayr; Stefan Moritz; Stefanie Beck; Sebastian G Wicha; Frieder Kees; Charlotte Kloft; Thomas Steinke
Journal:  J Clin Pharmacol       Date:  2015-09-18       Impact factor: 3.126

10.  Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniae.

Authors:  Piergiorgio Cojutti; Assunta Sartor; Elda Righi; Claudio Scarparo; Matteo Bassetti; Federico Pea
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191
  10 in total
  1 in total

1.  Evaluation of the Accuracy of Standard Renal Function Equations in Critically Ill Patients with Subarachnoid Hemorrhage.

Authors:  Michael A Wells; Kathryn Morbitzer; Denise H Rhoney
Journal:  Neurocrit Care       Date:  2020-06       Impact factor: 3.210
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.